Clinical Trial Results

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

PHASE1INTERVENTIONAL Atlanta, Georgia

RECRUITING

Clinical Pre-screening Protocol for Ovarian Cancer

N/AOBSERVATIONAL Tampa, Florida +4 more

RECRUITING

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

PHASE2INTERVENTIONAL Atlanta, Georgia +4 more

RECRUITING

Pancreatic Cancer Early Detection Consortium

N/AOBSERVATIONAL Phoenix, Arizona +4 more

RECRUITING

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

NAINTERVENTIONAL Atlanta, Georgia

RECRUITING

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

N/AOBSERVATIONAL San Francisco, California +4 more

RECRUITING

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

N/AOBSERVATIONAL Phoenix, Arizona +4 more

RECRUITING

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

PHASE3INTERVENTIONAL Anchorage, Alaska +4 more

RECRUITING

A Beta-only IL-2 ImmunoTherapY Study

PHASE1, PHASE2INTERVENTIONAL San Diego, California +4 more

RECRUITING

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

PHASE1, PHASE2INTERVENTIONAL Tucson, Arizona +4 more

RECRUITING

Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers

PHASE2INTERVENTIONAL Atlanta, Georgia +2 more

RECRUITING

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

PHASE2INTERVENTIONAL Atlanta, Georgia +4 more

RECRUITING

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

NAINTERVENTIONAL Anchorage, Alaska +4 more

RECRUITING

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more

RECRUITING

Connect for Cancer Prevention Study (Connect)

N/AOBSERVATIONAL Denver, Colorado +4 more

RECRUITING

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

PHASE1INTERVENTIONAL Norwalk, Connecticut +4 more

RECRUITING

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

PHASE1INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Childhood Cancer Predisposition Study (CCPS)

N/AOBSERVATIONAL Atlanta, Georgia +4 more

RECRUITING

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

PHASE1, PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

PHASE2INTERVENTIONAL Duarte, California +4 more

RECRUITING

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING